Dr. Nathan Robison, MD
Claim this profileChildren's Hospital Los Angeles
Area of expertise
Brain Tumor
Nathan Robison, MD has run 13 trials for Brain Tumor. Some of their research focus areas include:
Brain Cancer
Nathan Robison, MD has run 9 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Children's Hospital Los Angeles
Children's Hospital Of Los Angeles
Clinical Trials Nathan Robison, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting
2 awards
Phase 3
Sodium Thiosulfate
for Hearing Loss in Medulloblastoma
This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers to the chance of the cancer coming back after treatment. Subjects with low-risk medulloblastoma typically have a lower chance of the cancer coming back than subjects with average-risk medulloblastoma. Although treatment for newly diagnosed average-risk and low-risk medulloblastoma is generally effective at treating the cancer, there are still concerns about the side effects of such treatment. Side effects or unintended health conditions that arise due to treatment include learning difficulties, hearing loss or other issues in performing daily activities. Standard therapy for newly diagnosed average-risk or low-risk medulloblastoma includes surgery, radiation therapy, and chemotherapy (including cisplatin). Cisplatin may cause hearing loss as a side effect. In the average-risk medulloblastoma patients, this trial tests whether the addition of sodium thiosulfate (STS) to standard of care chemotherapy and radiation therapy reduces hearing loss. Previous studies with STS have shown that it may help reduce or prevent hearing loss caused by cisplatin. In the low-risk medulloblastoma patients, the study tests whether a less intense therapy (reduced radiation) can provide the same benefits as the more intense therapy. The less intense therapy may cause fewer side effects. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. The overall goals of this study are to see if giving STS along with standard treatment (radiation therapy and chemotherapy) will reduce hearing loss in medulloblastoma patients and to compare the overall outcome of patients with medulloblastoma treated with STS to patients treated without STS on a previous study in order to make sure that survival and recurrence of tumor is not worsened.
Recruiting
3 awards
Phase 3
More about Nathan Robison, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Nathan Robison, MD has experience with
- Radiation Therapy
- Selumetinib
- SurVaxM
- Optune System
- Hydroxychloroquine
- Dabrafenib
Breakdown of trials Nathan Robison, MD has run
Brain Tumor
Brain Cancer
Diffuse Intrinsic Pontine Glioma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nathan Robison, MD specialize in?
Nathan Robison, MD focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are Stage II.
Is Nathan Robison, MD currently recruiting for clinical trials?
Yes, Nathan Robison, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Nathan Robison, MD has studied deeply?
Yes, Nathan Robison, MD has studied treatments such as Radiation Therapy, Selumetinib, SurVaxM.
What is the best way to schedule an appointment with Nathan Robison, MD?
Apply for one of the trials that Nathan Robison, MD is conducting.
What is the office address of Nathan Robison, MD?
The office of Nathan Robison, MD is located at: Children's Hospital Los Angeles, Los Angeles, California 90026 United States. This is the address for their practice at the Children's Hospital Los Angeles.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.